Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Oncolytics Biotech reports tumor stabilization or shrinkage in REOLYSIN study
The Fly on the Wall
Tuesday, April 8, 2014 - 8:11am
tags:
Oncolytics, Reolysin, head and neck cancer
Disclosing Doctors' Medicare Pay Might Be 'Pretty Damning'
Bloomberg Businessweek
Tuesday, April 8, 2014 - 8:08am
tags:
Medicare, physicians
Europe backs more transparent, simpler clinical trial rules
Reuters
Monday, April 7, 2014 - 5:10pm
tags:
Europe, clinical trials, transparency
One Thing Drug Companies Won’t Do On Social Media
WSJ Online
Monday, April 7, 2014 - 5:09pm
tags:
social media, clinical trials
Biogen Idec May Have Seeds For Next-Gen MS Drugs
Investors.com
Monday, April 7, 2014 - 5:08pm
tags:
MS, Biogen Idec, multiple sclerosis, BIIB-061, remylination, Tecfidera
Takeda Showed Disregard in Handling Diabetes Drug, Jury Told
Bloomberg
Monday, April 7, 2014 - 5:07pm
tags:
Takeda, diabetes, Actos
GlaxoSmithKline Faces Bribery Allegations Yet Again, This Time in Iraq
Wall St Cheat Sheet
Monday, April 7, 2014 - 5:04pm
tags:
GSK, Iraq, China, bribery
If Glaxo's CEO wants to be Mr. Clean, he needs to pick up a broom
Fierce Pharma Marketing
Monday, April 7, 2014 - 1:04pm
tags:
GSK, Pharma CEOs, Andrew Witty
Hologic, GE, PositiveID land near $100M in Defense contracts
Mass Device
Monday, April 7, 2014 - 1:00pm
tags:
General Electric, PositiveID, devices, Hologic, defense contracts
Immunomedics reports results from three IMMU-130 phase I trials
Yahoo/Fly on the Wall
Monday, April 7, 2014 - 12:59pm
tags:
Immunomedics, IMMU-130, colorectal cancer
Boehringer Ingelheim's Oral Anticoagulant Gains New Indication
Forbes
Monday, April 7, 2014 - 12:57pm
tags:
Boehringer Ingelheim, anticlotting, Pradaxa, deep venous thrombosis, DVT, pulmonary embolism
FDA Keeps Driving Up Future Cost of Inhalable Insulin
Yahoo/247WallStreet
Monday, April 7, 2014 - 12:56pm
tags:
FDA, inhaled insulin, diabetes, Afrezza, MannKind
A Physician-Businessman's Views Of Gilead, With Emphasis On Sovaldi
Seeking Alpha
Monday, April 7, 2014 - 12:54pm
tags:
physicians, Sovaldi, Gilead Sciences, hepatitis C
FDA Breakthrough Therapy Designation For Novartis' Bexsero Vaccine To Prevent Meningitis B
Forbes
Monday, April 7, 2014 - 12:53pm
tags:
FDA, Novartis, Bexsero, vaccines, breakthrough therapies, meningitis B
Puma drug better than Herceptin in HER2 breast cancers -trial
Reuters
Monday, April 7, 2014 - 10:33am
tags:
Herceptin, Puma Biotechnology, HER2 Inhibitor, breast cancer, neratinib
Biotech's breathless quarter of IPOs brings in $2.1B for R&D
Fierce Biotech
Monday, April 7, 2014 - 10:30am
tags:
biotech, IPOs
This Biotech Market Could Quadruple -- 3 Stocks To Profit
Yahoo/Street Authority
Monday, April 7, 2014 - 10:28am
tags:
vaccines, Merck, Gardasil, Pfizer, Prevnar 13, Novavax, NanoViricides, Inovio
Novartis AG Seeks to Pump More Value into its R&D
Motley Fool
Monday, April 7, 2014 - 10:25am
tags:
Novartis, R&D
FirstWord Lists – The Quarterly: 10 key pharma events that occurred in Q1
First Word Pharma
Monday, April 7, 2014 - 10:24am
tags:
immuno-oncology, Sovaldi, Gilead Sciences, Teva Pharmaceuticals, Copaxone, GSK, Breo Ellipta, Forest Labs, Actavis, M&A, Affordable Care Act, biosimilars, PCSK9 inhibitors
Should Med School Leaders Serve On Pharma Boards?
Forbes
Monday, April 7, 2014 - 10:00am
tags:

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.